Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello, Martin L Miller, Bülent Arman Aksoy, Yasin Senbabaoglu, Nikolaus Schultz, Chris Sander, Giovanni Ciriello, Martin L Miller, Bülent Arman Aksoy, Yasin Senbabaoglu, Nikolaus Schultz, Chris Sander
Abstract
Cancer therapy is challenged by the diversity of molecular implementations of oncogenic processes and by the resulting variation in therapeutic responses. Projects such as The Cancer Genome Atlas (TCGA) provide molecular tumor maps in unprecedented detail. The interpretation of these maps remains a major challenge. Here we distilled thousands of genetic and epigenetic features altered in cancers to ∼500 selected functional events (SFEs). Using this simplified description, we derived a hierarchical classification of 3,299 TCGA tumors from 12 cancer types. The top classes are dominated by either mutations (M class) or copy number changes (C class). This distinction is clearest at the extremes of genomic instability, indicating the presence of different oncogenic processes. The full hierarchy shows functional event patterns characteristic of multiple cross-tissue groups of tumors, termed oncogenic signature classes. Targetable functional events in a tumor class are suggestive of class-specific combination therapy. These results may assist in the definition of clinical trials to match actionable oncogenic signatures with personalized therapies.
Figures
References
- Vogelstein B, et al. Cancer genome landscapes. Science. 2013;339:1546–1558.
- Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013;153:17–37.
- Hudson TJ, et al. International network of cancer genome projects. Nature. 2010;464:993–998.
- Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumors. Nature. 2012;490:61–70.
- Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73.
- Garraway LA, Verweij J, Ballman KV. Precision oncology: an overview. J. Clin. Oncol. 2013;31:1803–1805.
- Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J. Clin. Oncol. 2013;31:1806–1814.
- Greenman C, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153–158.
- Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061–1068.
- Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615.
- Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337.
- Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519–525.
- Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013;368:2059–2074.
- Beroukhim R, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA. 2007;104:20007–20012.
- Dees ND, et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 2012;22:1589–1598.
- Banerji S, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486:405–409.
- Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 2007;16(Spec No 1):R50–R59.
- Newman ME. Fast algorithm for detecting community structure in networks. Phys. Rev. E. 2004;69:066133.
- Wang X, et al. Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors. Int. J. Cancer. 2004;112:636.
- Wu JN, Roberts CW. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov. 2013;3:35–43.
- Filippova GN, et al. Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity. Cancer Res. 2002;62:48–52.
- Filippova GN, et al. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol. Cell Biol. 1996;16:2802–2813.
- Quitschke WW, Taheny MJ, Fochtmann LJ, Vostrov AA. Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene. Nucleic Acids Res. 2000;28:3370–3378.
- Imoto I, et al. Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas. Cancer Res. 2003;63:5691–5696.
- Chiang WF, et al. Increase of ZASC1 gene copy number in recurrent oral carcinoma. Oral Dis. 2011;17:53–59.
- Janku F, et al. PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. J. Clin. Oncol. 2012;30:777–782.
- Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat. Rev. Cancer. 2011;11:558–572.
- Guha M. Blockbuster dreams for Pfizer’s CDK inhibitor. Nat. Biotechnol. 2013;31:187.
- Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–404.
- Newman ME. Modularity and community structure in networks. Proc. Natl. Acad. Sci. USA. 2006;103:8577–8582.
- Fortunato S, Barthelemy M. Resolution limit in community detection. Proc. Natl. Acad. Sci. USA. 2007;104:36–41.
- Schuetz P, Caflisch A. Efficient modularity optimization by multistep greedy algorithm and vertex mover refinement. Phys. Rev. E. 2008;77:046112.
- Davis A, Gardner BB, Gardner MR, Warner WL. Deep South: A Social Anthropological Study of Caste and Class. Chicago: The University of Chicago Press; 1941.
- Guimerà R, Sales-Pardo M, Amaral LA. Module identification in bipartite and directed networks. Phys. Rev. E. 2007;76:036102.
- Scott J, Hughes M. The Anatomy of Scottish Capital: Scottish Companies and Scottish Capital, 1900–1979. London: Croom Helm; 1980.
- Barber MJ. Modularity and community detection in bipartite networks. Phys. Rev. E. 2007;76:066102.
- Henning C. Cluster-wise assessment of cluster stability. Comput. Stat. Data Anal. 2007;52:258–271.
Source: PubMed